Parentese Speech for Autism
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Parentese Speech for autism?
Is Parentese Speech safe for use in children with autism?
How does the treatment Parentese Speech differ from other treatments for autism?
Parentese Speech is unique because it involves caregivers using a playful and exaggerated speech style to engage children with autism, which can help improve their language and social skills. Unlike other treatments that may focus on direct interventions, this approach leverages the natural parent-child interaction to support development.710111213
What is the purpose of this trial?
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
Research Team
Pumpki L. Su, PhD
Principal Investigator
University of Texas at Dallas
Eligibility Criteria
This trial is for children with Autism or related neurodevelopmental disorders. It aims to see if a special way of speaking called 'parentese' helps them learn new words. Children must have a diagnosis of autism to join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Video-based Word Learning
Participants engage in a video-based word learning paradigm to determine the effect of recorded parentese on novel word learning
Live Interaction Word Learning
Participants engage in live interaction sessions to determine the effect of live parentese on novel word learning
Follow-up
Participants are monitored for word learning accuracy and response to auditory input
Treatment Details
Interventions
- Parentese Speech
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at Dallas
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator